For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250908:nRSH4550Ya&default-theme=true
RNS Number : 4550Y Primary Health Properties PLC 08 September 2025
Primary Health Properties PLC
Director's & PDMR Dealings - LTIP Vesting
Primary Health Properties PLC (the "Company" or "PHP"), one of the UK's
leading investors in modern primary healthcare facilities, announces that
Richard Howell, Chief Financial Officer, together with a further person
discharging managerial responsibility ("PDMR"), have received Ordinary Shares
of 12.5 pence each in the Company ("Ordinary Shares") under the terms of the
Company's Long-Term Incentive Plan ("LTIP") (the "Vesting").
Following conclusion of the recent extended closed period, the awards vested
on 8 September 2025 for nil consideration pursuant to a conditional award made
on 21 February 2022. For both Mr Howell and Mr Austin, the number of
Ordinary Shares which vested is stated after the deduction of the relevant
taxation and National Insurance charges.
Director Number of shares vesting
Richard Howell 101,556
PDMR
David Austin 23,552
All Ordinary Shares in connection with the Vesting will be transferred to the
relevant individuals from the Company's employee benefit trust ("EBT").
Details of the operation of the LTIP are set out in the Company's 2024 Report
and Accounts.
Details of the transactions referenced above are included below in accordance
with Article 19 of the retained EU law version of the Market Abuse Regulation
(Regulation 596/2014).
1 Details of the person discharging managerial responsibilities/persons closely
associated
(a) Name Richard Howell
2 Reason for notification
(a) Position/Status Chief Financial Officer
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Vesting of conditional share awards under the Company's LTIP
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 101,556
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 8 September 2025
(f) Place of transaction London Stock Exchange (XLON)
1 Details of the person discharging managerial responsibilities/person closely
associated
(a) Name David Austin
2 Reason for notification
(a) Position/Status PDMR
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date: and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument, type of instrument and identification Ordinary shares of 12.5p
code
ISIN: GB00BYRJ5J14
(b) Nature of transaction Vesting of conditional share awards under the Company's LTIP
(c) Price(s) and volume(s) Price(s) Volume(s)
Nil cost 23,552
(d) Aggregated Information Single transaction: N/A
(e) Date of transaction 8 September 2025
(f) Place of transaction London Stock Exchange (XLON)
More information on Primary Health Properties PLC can be found on
www.phpgroup.co.uk
Further details for enquiries:
Mark Davies via Burson Buchanan
Chief Executive Officer
Tel: +44 (0) 20 7466 5066
Richard Howell via Burson Buchanan
Chief Financial Officer Tel: +44 (0) 20 7466 5066
Stephanie Whitmore (Burson Buchanan)
Tel: +44 (0) 20 7466 5066
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBXGDCBXGDGUI